Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 1/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | CPB1 | P15086 | 1/20 | 0.53 |
| ▸ | MGLL | Q99685 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | SLC18A3 | Q16572 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15155929 | 0.98 | SRD5A2 (0.67) | SRD5A2MCL1HTR2ACPB1MGLL | |
| SCHEMBL33443 | 0.98 | SRD5A2 (0.67) | SRD5A2MCL1HTR2ACPB1MGLL | |
| SCHEMBL1427963 | 0.98 | SRD5A2 (0.67) | SRD5A2MCL1HTR2ACPB1MGLL | |
| Bicarbonate SCHEMBL6612782 | 0.96 | SRD5A2 (0.65) | SRD5A2MCL1HTR2ACPB1MGLL | |
| SCHEMBL3113279 | 0.95 | SRD5A2 (0.58) | SRD5A2MCL1HTR2ACPB1MGLL | |
| SCHEMBL324342 | 0.91 | HTR2A (0.56) | SRD5A2MCL1HTR2ACPB1MGLL | |
| SCHEMBL18428493 | 0.91 | HTR2A (0.56) | SRD5A2MCL1HTR2ACPB1MGLL | |
| Bicarbonate SCHEMBL11468689 | 0.88 | HTR2A (0.54) | SRD5A2MCL1HTR2ACPB1MGLL | |
| SCHEMBL28262911 | 0.87 | SRD5A2 (0.56) | SRD5A2MCL1HTR2ACPB1MGLL | |
| SCHEMBL22137390 | 0.86 | SRD5A2 (0.54) | SRD5A2MCL1HTR2ACPB1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116046945-B | Method for detecting related substances of penehyclidine hydrochloride injection by high performance liquid chromatography | 上海旭东海普药业有限公司 | 2025-03-11 | — | — | CN | claimed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| CN-118619939-A | Synthesis method of penehyclidine hydrochloride | 国药集团工业有限公司廊坊分公司 | 2024-09-10 | — | — | CN | claimed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118027260-A | High-selectivity polymer material with adjustable repeating unit carbon skeleton structure and preparation method thereof | 大连理工大学 | 2024-05-14 | — | — | CN | claimed |
| CN-116514800-A | Preparation method of penehyclidine hydrochloride | 湖南一格制药有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-116420575-A | Stemona seed direct seeding cultivation method | 重庆市中药研究院 | 2023-07-14 | — | — | CN | claimed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | claimed |
| CN-116046945-A | Method for detecting related substances of penehyclidine hydrochloride injection by high performance liquid chromatography | 上海旭东海普药业有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-107337595-A | Synthesis process of cyclopentyl phenyl ketone | 海门华祥医药科技有限公司 | 2017-11-10 | — | — | CN | claimed |
| CN-106431832-A | Alpha-cyclopentyl (phenyl) methanol synthesis and resolution method | 陈永军 | 2017-02-22 | — | — | CN | claimed |
| CN-105753682-A | Preparation method of cyclopentyl phenyl ketone | 中国科学院成都有机化学有限公司 | 2016-07-13 | — | — | CN | claimed |
| CN-104237392-A | Method of detecting impurities in penehyclidine | CHONGQING XIANYANG MEDICINE SCIENCE & TECHNOLOGY CO LTD | 2014-12-24 | — | — | CN | claimed |
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-07-15 | — | — | US | claimed |
| WO-2008121074-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | claimed |
| US-20040006243-A1 | Method of producing oxybutynin and its derivatives | THE UNIVERSITY OF TOKYO (JP) | 2004-01-08 | — | — | US | claimed |
| US-6323243-B1 | AROMATIC ETHER WITH AMINE OR AMIDE GROUPS | WARNER-LAMBERT COMPANY | 2001-11-27 | — | — | US | claimed |
| US-6180677-B1 | ANTIEPILEPSY AGENT | WARNER-LAMBERT COMPANY | 2001-01-30 | — | — | US | claimed |
| WO-2000006535-A1 | TYROSINE-DERIVED COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 2000-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | TDO2, AOX1, DAO | SRD5A2 921/4885MCL1 2565/4885HTR2A 3196/4885 |
| US-20040006243-A1 | Method of producing oxybutynin and its derivatives | KHK, BCKDK, AKR1B10 | SRD5A2 172/4885MCL1 2080/4885HTR2A 2832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.